BG108220A - Заместени в 6-та позиция индолинони и тяхното използване като инхибитори на киназа - Google Patents

Заместени в 6-та позиция индолинони и тяхното използване като инхибитори на киназа Download PDF

Info

Publication number
BG108220A
BG108220A BG108220A BG10822003A BG108220A BG 108220 A BG108220 A BG 108220A BG 108220 A BG108220 A BG 108220A BG 10822003 A BG10822003 A BG 10822003A BG 108220 A BG108220 A BG 108220A
Authority
BG
Bulgaria
Prior art keywords
alkyl
group
amino
phenyl
carbonyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
BG108220A
Other languages
Bulgarian (bg)
English (en)
Inventor
Frank Hilberg
Armin Heckel
Thorsten Lehmann-Lintz
Gerald J. Roth
Joerg Kley
Jacobus Van Meel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH Co KG
Original Assignee
Boehringer Ingelheim Pharma GmbH Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma GmbH Co KG filed Critical Boehringer Ingelheim Pharma GmbH Co KG
Publication of BG108220A publication Critical patent/BG108220A/bg
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/34Oxygen atoms in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08Bridged systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BG108220A 2001-04-06 2003-10-01 Заместени в 6-та позиция индолинони и тяхното използване като инхибитори на киназа Pending BG108220A (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10117204A DE10117204A1 (de) 2001-04-06 2001-04-06 In 6-Stellung substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel
PCT/EP2002/003583 WO2002081445A1 (de) 2001-04-06 2002-03-30 In 6-stellung substituierte indoline und ihre verwendung als kinase-inhibitoren

Publications (1)

Publication Number Publication Date
BG108220A true BG108220A (bg) 2004-09-30

Family

ID=7680648

Family Applications (1)

Application Number Title Priority Date Filing Date
BG108220A Pending BG108220A (bg) 2001-04-06 2003-10-01 Заместени в 6-та позиция индолинони и тяхното използване като инхибитори на киназа

Country Status (23)

Country Link
US (1) US6858641B2 (hu)
EP (1) EP1379501A1 (hu)
JP (1) JP2004525173A (hu)
KR (1) KR20030090712A (hu)
CN (1) CN1509270A (hu)
AR (1) AR035813A1 (hu)
BG (1) BG108220A (hu)
BR (1) BR0208900A (hu)
CA (1) CA2442695A1 (hu)
CZ (1) CZ20032975A3 (hu)
DE (1) DE10117204A1 (hu)
EA (1) EA200301005A1 (hu)
EC (1) ECSP034776A (hu)
EE (1) EE200300491A (hu)
HU (1) HUP0303737A3 (hu)
IL (1) IL158254A0 (hu)
MX (1) MXPA03008896A (hu)
NO (1) NO20034434L (hu)
PE (1) PE20021058A1 (hu)
PL (1) PL366458A1 (hu)
SK (1) SK12412003A3 (hu)
WO (1) WO2002081445A1 (hu)
ZA (1) ZA200307306B (hu)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10233500A1 (de) * 2002-07-24 2004-02-19 Boehringer Ingelheim Pharma Gmbh & Co. Kg 3-Z-[1-(4-(N-((4-Methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylen]-6-methoxycarbonyl-2-indolinon-Monoethansulfonat und dessen Verwendung als Arzneimittel
US7148249B2 (en) * 2002-09-12 2006-12-12 Boehringer Ingelheim Pharma Gmbh & Co. Kg Indolinones substituted by heterocycles, the preparation thereof and their use as medicaments
JP4879492B2 (ja) * 2002-11-27 2012-02-22 アラーガン、インコーポレイテッド 疾患の治療のためのキナーゼ阻害剤
US20060154939A1 (en) * 2004-12-24 2006-07-13 Boehringer Ingelheim International Gmbh Medicaments for the Treatment or Prevention of Fibrotic Diseases
PE20060777A1 (es) 2004-12-24 2006-10-06 Boehringer Ingelheim Int Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas
PE20061155A1 (es) * 2004-12-24 2006-12-16 Boehringer Ingelheim Int Derivados de indolinona como agentes para el tratamiento o la prevencion de enfermedades fibroticas
WO2007057397A1 (en) * 2005-11-15 2007-05-24 Boehringer Ingelheim International Gmbh Treatment of cancer
ATE510827T1 (de) 2007-10-12 2011-06-15 Ingenium Pharmaceuticals Gmbh Inhibitoren von proteinkinasen
PE20091445A1 (es) * 2007-12-03 2009-10-19 Boehringer Ingelheim Int Derivados de indolinona y procedimiento para su fabricacion
US20170065529A1 (en) 2015-09-09 2017-03-09 Boehringer Ingelheim International Gmbh Pharmaceutical dosage form for immediate release of an indolinone derivative
US8344018B2 (en) * 2008-07-14 2013-01-01 Gilead Sciences, Inc. Oxindolyl inhibitor compounds
PE20110213A1 (es) 2008-07-29 2011-04-16 Boehringer Ingelheim Int Derivados de indolinona como inhibidores de quinasa
US8518948B2 (en) 2010-03-10 2013-08-27 Ingenium Pharmaceuticals Gmbh Inhibitors of protein kinases
CN102267934B (zh) * 2010-06-02 2013-04-17 金凯美(大连)医药科技有限公司 一种6-甲氧羰基吲哚酮的制备方法
KR20180128390A (ko) 2015-12-24 2018-12-03 레스피버트 리미티드 인돌리논 화합물과 섬유성 질환의 치료에서 이의 용도
EP3426649B1 (en) 2016-03-08 2020-07-22 Respivert Limited Indole derivatives and their use as protein kinase inhibitors

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0929520B1 (en) * 1996-08-23 2005-11-02 Sugen, Inc. Indolinone combinatorial libraries and related products and methods for the treatment of disease
GB9718913D0 (en) * 1997-09-05 1997-11-12 Glaxo Group Ltd Substituted oxindole derivatives
US6043254A (en) * 1998-04-03 2000-03-28 Boehringer Ingelheim Pharma Kg Indolinones having kinase-inhibiting activity
DE19816624A1 (de) 1998-04-15 1999-10-21 Boehringer Ingelheim Pharma Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel
US6169106B1 (en) * 1998-04-15 2001-01-02 Boehringer Ingelheim Pharma Kg Indolinones having kinase inhibitory activity
DE19824922A1 (de) * 1998-06-04 1999-12-09 Boehringer Ingelheim Pharma Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel
US6319918B1 (en) * 1998-06-04 2001-11-20 Boehringer Ingelheim Pharma Kg Substituted indolinones with kinase inhibitory activity
DE19924401A1 (de) 1999-05-27 2000-11-30 Boehringer Ingelheim Pharma Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel
DE19940829A1 (de) 1999-08-27 2001-03-01 Boehringer Ingelheim Pharma Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel
MXPA02002097A (es) 1999-08-27 2002-11-07 Boehringer Ingelheim Pharma Indolinas sustituidas como inhibidoras de la tirosina cinasa.
DE10042696A1 (de) 2000-08-31 2002-03-14 Boehringer Ingelheim Pharma In 6-Stellung substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel
UA75054C2 (uk) 1999-10-13 2006-03-15 Бьорінгер Інгельхайм Фарма Гмбх & Ко. Кг Заміщені в положенні 6 індолінони, їх одержання та їх застосування як лікарського засобу

Also Published As

Publication number Publication date
HUP0303737A3 (en) 2004-09-28
CZ20032975A3 (cs) 2004-02-18
EE200300491A (et) 2004-02-16
WO2002081445A1 (de) 2002-10-17
US20030092756A1 (en) 2003-05-15
KR20030090712A (ko) 2003-11-28
EP1379501A1 (de) 2004-01-14
NO20034434D0 (no) 2003-10-03
BR0208900A (pt) 2004-04-20
JP2004525173A (ja) 2004-08-19
AR035813A1 (es) 2004-07-14
HUP0303737A2 (hu) 2004-03-01
DE10117204A1 (de) 2002-10-10
ZA200307306B (en) 2004-08-31
ECSP034776A (es) 2003-12-01
US6858641B2 (en) 2005-02-22
SK12412003A3 (sk) 2004-04-06
CN1509270A (zh) 2004-06-30
PE20021058A1 (es) 2003-01-20
MXPA03008896A (es) 2003-12-08
CA2442695A1 (en) 2002-10-17
EA200301005A1 (ru) 2004-04-29
IL158254A0 (en) 2004-05-12
PL366458A1 (en) 2005-02-07
NO20034434L (no) 2003-10-03

Similar Documents

Publication Publication Date Title
US6762180B1 (en) Substituted indolines which inhibit receptor tyrosine kinases
CA2387013C (en) 6-position substituted indolinones, the preparation thereof and their use as pharmaceutical compositions
KR100588250B1 (ko) 키나제 및 사이클린/cdk 착체에 대한 억제 효과가 있는 치환된 인돌리논, 이의 제조방법 및 이를 함유하는 약제학적 조성물
US6794395B1 (en) Substituted indolinones, their manufacture and their use as medicaments
BG108220A (bg) Заместени в 6-та позиция индолинони и тяхното използване като инхибитори на киназа
US7148249B2 (en) Indolinones substituted by heterocycles, the preparation thereof and their use as medicaments
AU6086399A (en) Novel substituted indolinones with an inhibitory effect on various kinases and cyclin/cdk complexes
US7169936B2 (en) Indolinone derivatives substituted in the 6-position, their preparation and their use as medicaments
AU4370799A (en) Substituted indolinones, the production thereof and their use as medicaments
HRP20050069A2 (en) Indoline derivatives substituted in position 6, production and use thereof as medicaments
US6169106B1 (en) Indolinones having kinase inhibitory activity
US7160901B2 (en) Substituted indolinones, preparation thereof and their use as pharmaceutical compositions
CZ20003788A3 (cs) Substituované indolinony